Albuterol stearate
| Code | Size | Price |
|---|
| TAR-T25030-5mg | 5mg | £850.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
| TAR-T25030-50mg | 50mg | £1,661.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
| TAR-T25030-100mg | 100mg | £2,079.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Documents
Further Information
Bioactivity:
Albuterol stearate is a salt of Albuterol. Albuterol is a short-acting, selective beta2-adrenergic receptor agonist used in the treatment of asthma and COPD. It is 29 times more selective for beta2 receptors than beta1 receptors.
CAS:
149234-09-3
Formula:
C31H57NO5
Molecular Weight:
523.799
Purity:
0.98
SMILES:
CC(C)(C)NC[C@H](O)c1ccc(O)c(CO)c1.CCCCCCCCCCCCCCCCCC(O)=O
References
1. Stank K, Steckel H. Physico-chemical characterisation of surface modified particles for inhalation. Int J Pharm. 2013 May 1;448(1):9-18. doi: 10.1016/j.ijpharm.2013.03.009. Epub 2013 Mar 18. PubMed PMID: 23518364.
2. Tuli RA, George GA, Dargaville TR, Islam N. Studies on the effect of the size of polycaprolactone microspheres for the dispersion of salbutamol sulfate from dry powder inhaler formulations. Pharm Res. 2012 Sep;29(9):2445-55. doi: 10.1007/s11095-012-0772-y. Epub 2012 May 15. Erratum in: Pharm Res. 2013 Jan;30(1):303. PubMed PMID: 22584947.
3. Tuli RA, Dargaville TR, George GA, Islam N. Polycaprolactone microspheres as carriers for dry powder inhalers: effect of surface coating on aerosolization of salbutamol sulfate. J Pharm Sci. 2012 Feb;101(2):733-45. doi: 10.1002/jps.22777. Epub 2011 Sep 28. PubMed PMID: 21956254.
4. Zhou QT, Qu L, Larson I, Stewart PJ, Morton DA. Improving aerosolization of drug powders by reducing powder intrinsic cohesion via a mechanical dry coating approach. Int J Pharm. 2010 Jul 15;394(1-2):50-9. doi: 10.1016/j.ijpharm.2010.04.032. Epub 2010 May 7. PubMed PMID: 20435112.